US Patent Issued to DNAe Diagnostics on April 21 for "Compositions, kits and methods for isolating target polynucleotides" (British, American Inventors)

ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,864, issued on April 21, was assigned to DNAe Diagnostics Ltd. (London).

"Compositions, kits and methods for isolating target polynucleotides" was invented by Norm Nelson (San Diego) and David Wooldridge (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are oligomers, compositions, kits, and methods for capturing target polynucleotides, e.g., for downstream applications such as amplification, library preparation, or sequencing. In some embodiments, a capture oligomer is provided or used that comprises a capture sequence that is annealed to a complement that prevents capture until the complement is displaced in a target-polynucl...